Merel Sanne Ekker1, Jamie Inge Verhoeven1, Ilonca Vaartjes2, Wilhelmus Martinus Tim Jolink3, Catharina Johanna Maria Klijn1,3, Frank-Erik de Leeuw1. 1. Radboud University Medical Centre, Donders Institute for Brain, Cognition, and Behaviour, Department of Neurology, Nijmegen, the Netherlands. 2. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. 3. Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.
Abstract
Importance: Stroke remains the second leading cause of death worldwide. Approximately 10% to 15% of all strokes occur in young adults. Information on prognosis and mortality specifically in young adults is limited. Objective: To determine short- and long-term mortality risk after stroke in young adults, according to age, sex, and stroke subtype; time trends in mortality; and causes of death. Design, Setting, and Participants: Registry- and population-based study in the Netherlands of 15 527 patients aged 18 to 49 years with first stroke between 1998 and 2010, and follow-up until January 1, 2017. Patients and outcomes were identified through linkage of the national Hospital Discharge Registry, national Cause of Death Registry, and the Dutch Population Register. Exposures: First stroke occurring at age 18 to 49 years, documented using International Classification of Diseases, Ninth Revision, and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, codes for ischemic stroke, intracerebral hemorrhage, and stroke not otherwise specified. Main Outcomes and Measures: Primary outcome was all-cause cumulative mortality in 30-day survivors at end of follow-up, stratified by age, sex, and stroke subtype, and compared with all-cause cumulative mortality in the general population. Results: The study population included 15 527 patients with stroke (median age, 44 years [interquartile range, 38-47 years]; 53.3% women). At end of follow-up, a total of 3540 cumulative deaths had occurred, including 1776 deaths within 30 days after stroke and 1764 deaths (23.2%) during a median duration of follow-up of 9.3 years (interquartile range, 5.9-13.1 years). The 15-year mortality in 30-day survivors was 17.0% (95% CI, 16.2%-17.9%). The standardized mortality rate compared with the general population was 5.1 (95% CI, 4.7-5.4) for ischemic stroke (observed mortality rate 12.0/1000 person-years [95% CI, 11.2-12.9/1000 person-years]; expected rate, 2.4/1000 person-years; excess rate, 9.6/1000 person-years) and the standardized mortality rate for intracerebral hemorrhage was 8.4 (95% CI, 7.4-9.3; observed rate, 18.7/1000 person-years [95% CI, 16.7-21.0/1000 person-years]; expected rate, 2.2/1000 person-years; excess rate, 16.4/1000 person-years). Conclusions and Relevance: Among young adults aged 18 to 49 years in the Netherlands who were 30-day survivors of first stroke, mortality risk compared with the general population remained elevated up to 15 years later.
Importance: Stroke remains the second leading cause of death worldwide. Approximately 10% to 15% of all strokes occur in young adults. Information on prognosis and mortality specifically in young adults is limited. Objective: To determine short- and long-term mortality risk after stroke in young adults, according to age, sex, and stroke subtype; time trends in mortality; and causes of death. Design, Setting, and Participants: Registry- and population-based study in the Netherlands of 15 527 patients aged 18 to 49 years with first stroke between 1998 and 2010, and follow-up until January 1, 2017. Patients and outcomes were identified through linkage of the national Hospital Discharge Registry, national Cause of Death Registry, and the Dutch Population Register. Exposures: First stroke occurring at age 18 to 49 years, documented using International Classification of Diseases, Ninth Revision, and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, codes for ischemic stroke, intracerebral hemorrhage, and stroke not otherwise specified. Main Outcomes and Measures: Primary outcome was all-cause cumulative mortality in 30-day survivors at end of follow-up, stratified by age, sex, and stroke subtype, and compared with all-cause cumulative mortality in the general population. Results: The study population included 15 527 patients with stroke (median age, 44 years [interquartile range, 38-47 years]; 53.3% women). At end of follow-up, a total of 3540 cumulative deaths had occurred, including 1776 deaths within 30 days after stroke and 1764 deaths (23.2%) during a median duration of follow-up of 9.3 years (interquartile range, 5.9-13.1 years). The 15-year mortality in 30-day survivors was 17.0% (95% CI, 16.2%-17.9%). The standardized mortality rate compared with the general population was 5.1 (95% CI, 4.7-5.4) for ischemic stroke (observed mortality rate 12.0/1000 person-years [95% CI, 11.2-12.9/1000 person-years]; expected rate, 2.4/1000 person-years; excess rate, 9.6/1000 person-years) and the standardized mortality rate for intracerebral hemorrhage was 8.4 (95% CI, 7.4-9.3; observed rate, 18.7/1000 person-years [95% CI, 16.7-21.0/1000 person-years]; expected rate, 2.2/1000 person-years; excess rate, 16.4/1000 person-years). Conclusions and Relevance: Among young adults aged 18 to 49 years in the Netherlands who were 30-day survivors of first stroke, mortality risk compared with the general population remained elevated up to 15 years later.
Authors: Magali Barbieri; John R Wilmoth; Vladimir M Shkolnikov; Dana Glei; Domantas Jasilionis; Dmitri Jdanov; Carl Boe; Timothy Riffe; Pavel Grigoriev; Celeste Winant Journal: Int J Epidemiol Date: 2015-06-23 Impact factor: 7.196
Authors: Dennis J Nieuwkamp; Ilonca Vaartjes; Ale Algra; Michiel L Bots; Gabriël J E Rinkel Journal: Int J Stroke Date: 2013-03-12 Impact factor: 5.266
Authors: I Vaartjes; J B Reitsma; A de Bruin; M Berger-van Sijl; M J Bos; M M B Breteler; D E Grobbee; M L Bots Journal: Eur J Neurol Date: 2008-12 Impact factor: 6.089
Authors: Jeannette Hofmeijer; L Jaap Kappelle; Ale Algra; G Johan Amelink; Jan van Gijn; H Bart van der Worp Journal: Lancet Neurol Date: 2009-03-05 Impact factor: 44.182
Authors: Michael Brainin; Tom Skyhøj Olsen; Angel Chamorro; Hans-Christoph Diener; José Ferro; Michael G Hennerici; Peter Langhorne; Johani Sivenius Journal: Cerebrovasc Dis Date: 2004 Impact factor: 2.762
Authors: Jukka Putaala; Antti J Metso; Tiina M Metso; Nina Konkola; Yvonn Kraemer; Elena Haapaniemi; Markku Kaste; Turgut Tatlisumak Journal: Stroke Date: 2009-02-26 Impact factor: 7.914
Authors: Michelle H Leppert; P Michael Ho; James Burke; Tracy E Madsen; Dawn Kleindorfer; Stefan Sillau; Stacie Daugherty; Cathy J Bradley; Sharon N Poisson Journal: Stroke Date: 2020-09-18 Impact factor: 7.914
Authors: Mina A Jacob; Merel S Ekker; Youssra Allach; Mengfei Cai; Karoliina Aarnio; Antonio Arauz; Marcel Arnold; Hee-Joon Bae; Lucrecia Bandeo; Miguel A Barboza; Manuel Bolognese; Pablo Bonardo; Raf Brouns; Batnairamdal Chuluun; Enkhzaya Chuluunbatar; Charlotte Cordonnier; Byambasuren Dagvajantsan; Stephanie Debette; Adi Don; Chris Enzinger; Esme Ekizoglu; Simon Fandler-Höfler; Franz Fazekas; Annette Fromm; Thomas Gattringer; Thiago F Hora; Christina Jern; Katarina Jood; Young Seo Kim; Steven Kittner; Timothy Kleinig; Catharina J M Klijn; Janika Kõrv; Vinod Kumar; Keon-Joo Lee; Tsong-Hai Lee; Noortje A M Maaijwee; Nicolas Martinez-Majander; João P Marto; Man M Mehndiratta; Victoria Mifsud; Vinícius Montanaro; Gisele Pacio; Vinod B Patel; Matthew C Phillips; Bartlomiej Piechowski-Jozwiak; Aleksandra Pikula; Jose Ruiz-Sandoval; Bettina von Sarnowski; Richard H Swartz; Kay-Sin Tan; David Tanne; Turgut Tatlisumak; Vincent Thijs; Miguel Viana-Baptista; Riina Vibo; Teddy Y Wu; Nilüfer Yesilot; Ulrike Waje-Andreassen; Alessandro Pezzini; Jukka Putaala; Anil M Tuladhar; Frank-Erik de Leeuw Journal: Neurology Date: 2021-12-14 Impact factor: 9.910
Authors: Lindsey R Kuohn; Audrey C Leasure; Julian N Acosta; Kevin Vanent; Santosh B Murthy; Hooman Kamel; Charles C Matouk; Lauren H Sansing; Guido J Falcone; Kevin N Sheth Journal: Neurology Date: 2020-09-11 Impact factor: 9.910
Authors: Allison S Hyngstrom; Jennifer N Nguyen; Michael T Wright; Sergey S Tarima; Brian D Schmit; David D Gutterman; Matthew J Durand Journal: J Appl Physiol (1985) Date: 2020-10-22
Authors: Muhammad K Ahmed; Haris Kamal; Jessica L Weiss; Annemarie Crumlish; Peyman Shirani; Robert N Sawyer; Ashkan Mowla Journal: Brain Circ Date: 2021-05-29